(DBI) Designer Brands - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2505651081

Footwear, Accessories, Handbags, Retail, E-Commerce

Dividends

Dividend Yield 2.41%
Yield on Cost 5y 3.16%
Yield CAGR 5y 18.92%
Payout Consistency 74.2%
Payout Ratio 500.0%
Risk via 5d forecast
Volatility 88.7%
Value at Risk 5%th 127%
Relative Tail Risk -12.82%
Reward TTM
Sharpe Ratio 0.85
Alpha 21.30
CAGR/Max DD -0.03
Character TTM
Hurst Exponent 0.626
Beta 1.918
Beta Downside 2.113
Drawdowns 3y
Max DD 81.72%
Mean DD 40.14%
Median DD 39.07%

Description: DBI Designer Brands November 15, 2025

Designer Brands Inc. (NYSE:DBI) designs, produces, and retails footwear and accessories across the United States and Canada through three operating segments-U.S. Retail, Canada Retail, and Brand Portfolio. Its product mix includes dress, casual, and athletic shoes, as well as handbags for men, women, and children, sold under proprietary labels such as Vince Camuto, Keds, Topo, Jessica Simpson, Lucky Brand, Le Tigre, and Hush Puppies, and distributed via DSW Designer Shoe Warehouse, The Shoe Co, Rubino, company-owned stores, e-commerce sites, and mobile apps.

Key recent metrics: FY 2023 revenue was approximately $2.2 billion, with comparable-store sales down about 5 % YoY, reflecting broader discretionary-spending pressure; however, e-commerce sales grew roughly 12 % year-over-year, outpacing the brick-and-mortar decline. The company carries a debt-to-equity ratio near 1.2, and its operating margin hovered around 5 % after a modest cost-restructuring effort. Sector-wide, consumer-price inflation and a tightening labor market remain primary drivers of foot-traffic volatility for apparel retailers.

For a deeper dive into DBI’s valuation metrics and scenario analysis, you may find ValueRay’s research platform useful.

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income (-31.8m TTM) > 0 and > 6% of Revenue (6% = 175.0m TTM)
FCFTA 0.02 (>2.0%) and ΔFCFTA 2.56pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 6.12% (prev 5.85%; Δ 0.26pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.03 (>3.0%) and CFO 61.4m > Net Income -31.8m (YES >=105%, WARN >=100%)
NO Net Debt/EBITDA fails (EBITDA <= 0)
Current Ratio 1.31 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (48.7m) change vs 12m ago -16.90% (target <= -2.0% for YES)
Gross Margin 48.19% (prev 31.44%; Δ 16.76pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 140.0% (prev 145.2%; Δ -5.22pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio -0.47 (EBITDA TTM -2.69m / Interest Expense TTM 71.1m) >= 6 (WARN >= 3)

Altman Z'' 1.22

(A) 0.09 = (Total Current Assets 751.9m - Total Current Liabilities 573.5m) / Total Assets 2.06b
(B) 0.03 = Retained Earnings (Balance) 66.5m / Total Assets 2.06b
(C) -0.02 = EBIT TTM -33.4m / Avg Total Assets 2.08b
(D) 0.63 = Book Value of Equity 1.11b / Total Liabilities 1.78b
Total Rating: 1.22 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 28.73

1. Piotroski 3.50pt
2. FCF Yield 2.87%
3. FCF Margin 1.49%
4. Debt/Equity 4.70
5. Debt/Ebitda data missing
6. ROIC - WACC (= -6.90)%
7. RoE -11.10%
8. Rev. Trend -81.99%
9. EPS Trend -49.94%

What is the price of DBI shares?

As of December 14, 2025, the stock is trading at USD 8.29 with a total of 1,896,440 shares traded.
Over the past week, the price has changed by +69.88%, over one month by +107.40%, over three months by +87.18% and over the past year by +60.13%.

Is DBI a buy, sell or hold?

Designer Brands has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold DBI.
  • Strong Buy: 0
  • Buy: 0
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the DBI price?

Issuer Target Up/Down from current
Wallstreet Target Price 4.8 -42.7%
Analysts Target Price 4.8 -42.7%
ValueRay Target Price 9.2 11.5%

DBI Fundamental Data Overview December 10, 2025

Market Cap USD = 240.3m (240.3m USD * 1.0 USD.USD)
P/E Forward = 9.5147
P/S = 0.0824
P/B = 0.861
P/EG = 2.61
Beta = 1.022
Revenue TTM = 2.92b USD
EBIT TTM = -33.4m USD
EBITDA TTM = -2.69m USD
Long Term Debt = 509.6m USD (from longTermDebt, last quarter)
Short Term Debt = 164.0m USD (from shortTermDebt, last quarter)
Debt = 1.32b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.28b USD (from netDebt column, last quarter)
Enterprise Value = 1.52b USD (240.3m + Debt 1.32b - CCE 44.9m)
Interest Coverage Ratio = -0.47 (Ebit TTM -33.4m / Interest Expense TTM 71.1m)
FCF Yield = 2.87% (FCF TTM 43.5m / Enterprise Value 1.52b)
FCF Margin = 1.49% (FCF TTM 43.5m / Revenue TTM 2.92b)
Net Margin = -1.09% (Net Income TTM -31.8m / Revenue TTM 2.92b)
Gross Margin = 48.19% ((Revenue TTM 2.92b - Cost of Revenue TTM 1.51b) / Revenue TTM)
Gross Margin QoQ = 43.65% (prev 42.96%)
Tobins Q-Ratio = 0.73 (Enterprise Value 1.52b / Total Assets 2.06b)
Interest Expense / Debt = 2.68% (Interest Expense 35.4m / Debt 1.32b)
Taxrate = 23.97% (3.56m / 14.8m)
NOPAT = -25.4m (EBIT -33.4m * (1 - 23.97%)) [loss with tax shield]
Current Ratio = 1.31 (Total Current Assets 751.9m / Total Current Liabilities 573.5m)
Debt / Equity = 4.70 (Debt 1.32b / totalStockholderEquity, last quarter 280.8m)
Debt / EBITDA = -473.8 (out of range, set to none) (Net Debt 1.28b / EBITDA -2.69m)
Debt / FCF = 29.29 (Net Debt 1.28b / FCF TTM 43.5m)
Total Stockholder Equity = 286.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.54% (Net Income -31.8m / Total Assets 2.06b)
RoE = -11.10% (Net Income TTM -31.8m / Total Stockholder Equity 286.2m)
RoCE = -4.20% (EBIT -33.4m / Capital Employed (Equity 286.2m + L.T.Debt 509.6m))
RoIC = -3.17% (negative operating profit) (NOPAT -25.4m / Invested Capital 802.8m)
WACC = 3.74% (E(240.3m)/V(1.56b) * Re(13.08%) + D(1.32b)/V(1.56b) * Rd(2.68%) * (1-Tc(0.24)))
Discount Rate = 13.08% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -10.96%
[DCF Debug] Terminal Value 51.49% ; FCFE base≈43.5m ; Y1≈28.6m ; Y5≈13.1m
Fair Price DCF = 3.36 (DCF Value 140.3m / Shares Outstanding 41.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -49.94 | EPS CAGR: -7.10% | SUE: -1.97 | # QB: 0
Revenue Correlation: -81.99 | Revenue CAGR: -3.74% | SUE: 0.08 | # QB: 0
EPS next Year (2027-01-31): EPS=0.10 | Chg30d=+0.049 | Revisions Net=+1 | Growth EPS=+121.6% | Growth Revenue=+2.6%

Additional Sources for DBI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle